维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

5篇 您的检索式：作者名="Truemper L"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	First analy-sis of the comp- letedMabthera International (MINT) trial in youngpatientswith low-ri- sk diffuse large B-cell lymphoma (DLBCL): addition ofrituximab to a CHOP-like regimen silgaificantly im-proves outcome of all patients with the identification of a veryfavorable subgroupwith IPI=0 and no bulky disease显示文摘	Pfreundschuhm Truemper L Gill D	2004	Blood2004，104，48：	1
	2	CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:a randomised controlled trial by the MabThera International Trial (MInT) Group显示文摘	Pfreundschuh M Truemper L Osterborg A	2006	Lancet Oncol2006，7，：	1
	3	Fist analysis of the completed mabthera imemational (MINT) trial in yong patients with tow - risk diffuse large B - cell lymphoma (DL- 13CL) : Addition of rituximab to a CHOP- like regimens sig- nlficandy improves outcome of al padems with the identifica- tion of a very favoralale subgroup with and no 10ulky disease 显示文摘	Pfreundschuch M Truemper L Gill D	2004	Blo:d2004，100，：	1
	4	First analysis of the completed Mabthera International (MINT) trial in young patients with low-risk diffuse large B-cell lymphoma (DLBCL) : addition of rituximab to a CHOP-like regimen significantly improves outcome of all patients with the identification of a very favorable subgroup with IPI = 0 and no bulky disease 显示文摘	PFREUNDSCHUH M TRUEMPER L GILL D	2004	Blood2004，104，48：	1
	5	2-weeky or 3-weekly CHOP with and without etoposide for patients ^60 years of age with aggressive non-Hodgkin's lymphoma(NHL):results of the completed NHL-B-2 trail of the DSHNHL显示文摘	Pfreundschuh M Truemper L Kloess M	2002	Ann Oncol2002，13，2：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费